ID   t-HUE1
AC   CVCL_UY91
DR   cancercelllines; CVCL_UY91
DR   Wikidata; Q98133061
RX   PubMed=1817644;
CC   Group: Serum/protein free medium cell line.
CC   Problematic cell line: Contaminated. Parent cell line (ECV-304) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 30 hours (PubMed=1817644).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2029 ! ECV-304
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
RX   PubMed=1817644;
RA   Kobayashi, Mieko
RA   Kondo, Masaaki
RA   Mitsui, Youji
RT   "Establishment of human endothelial cell lines in a serum-free culture
RT   and its application for expression of transfected prepro endothelin
RT   gene.";
RL   Hum. Cell 4:296-305(1991).
//